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ABSTRACT 
Global health spending share of low/middle income countries continues its long-term growth. BRICS nations remain to be 
major drivers of such change since 1990s. 
Governmental, private and out-of-pocket health expenditures were analyzed based on WHO sources. Medium-term 
projections of national health spending to 2025 were provided based on macroeconomic budgetary excess growth model. 
In terms of per capita spending Russia was highest in 2013. India's health expenditure did not match overall economic 
growth and fell to slightly less than 4% of GDP. Up to 2025 China will achieve highest excess growth rate of 2% and 
increase its GDP% spent on health care from 5.4% in 2012 to 6.6% in 2025. Russia's spending will remain highest among 
BRICS in absolute per capita terms reaching net gain from $1523 PPP in 2012 to $2214 PPP in   2025. 
In spite of BRICS' diversity, all countries were able to signiﬁcantly increase their investments in health care. The major 
setback was bold rise in out-of-pocket spending. Most of BRICS' growing share of global medical spending was heavily 
attributable to the overachievement of People's Republic of China. Such trend is highly likely to continue beyond 2025.  
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1. EVOLUTION OF NATIONAL MEDICAL SPENDING AND SYSTEMS 
The development of a modern national medical system requires four factors: Wealth, Longevity, Medical 
Technology, Medical Financing and Organization. Wealth provides a buffer against risk, freedom from 
malnutrition and the ability to invest in knowledge and social capital. Without longevity, the risk of sudden 
death dwarfs the marginal impact of medicine, making incremental progress less valuable. By the late 19 th 
Century, demographic transition (Lee, 2003) and continuous productivity improvements made wealth and 
longevity available to most citizens among the advancing group of industrialized nations. Discoveries regar- 
ding antiseptics, anesthesia, bacteria, diagnostics and the synthesis of organic chemicals laid the scientiﬁc 
groundwork for what would later become modern medical therapeutics. Precursors of modern organization and 
ﬁnancing were provided by the rise of specialty clinics in French Hospitals, Bismarck's health   insurance 
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scheme in Germany (Bärnighausen and Sauerborn, 2002), as well as medical licensure and the formation of 
friendly societies in England. The beginnings of modern medicine were clearly in place on the eve of the Great 
War in 1913, yet there was not yet any body of effective medical practice, nor any organized national systems 
of health care. Only after the passage of two world wars, the great depression and decades of scientiﬁc research 
did modern medical systems begin to take shape. Still nascent in the 1950s, most leading industrial nations had 
established national systems by 1975 that are still recognizable today (House, 2002). 
The creation of modern medicine was costly. Vast sums were required to fund new medical technology, 
continuous research and trained professionals. This forced the creation of extensive medical ﬁnancing 
networks, pooling social and private insurance with personal payments from patients, philanthropy and taxes. 
Even though per capita income was rising rapidly, medical expenditures grew even faster surging past 6% of 
GDP by 1975 (Getzen, 1991). 
It can be useful to group countries into four cohorts. The ﬁrst to develop national health systems were the 
European nations already industrialized in the 19th century inclusive of Russia, along with Australia, Canada, 
Japan, New Zealand and the USA that made up the original OECD. The second are those that subsequently 
aligned with the OECD and built their own national systems in the following decades such as the Czech 
Republic, Estonia, Hungary, Mexico, Poland, Slovak Republic, Slovenia, South Korea, Singapore and Turkey, 
often relying heavily on the initial cohort as models (Jakovljevic, 2013). A third cohort consisting of China, 
India, Brazil, South Africa and many other countries has now begun to follow. The legacy of the former Soviet 
Union was the historical Semashko system was the ﬁrst to deliver universal health coverage free of charge for 
all its citizens since the early 1930s (Semashko, 1934). It could be claimed that by 2020 a majority of the people 
in the world will be living in countries with comprehensive national systems to provide and ﬁnance health care 
(Getzen, 2014). Many emerging market countries are still in their formative stages, but are rapidly making 
progress. However, there is also a fourth cohort of less-developed countries that continues to struggle and has 
not yet been able to make organized health care widely and readily available to most of their citizens. 
 
 
2. DATA AND ESTIMATES OF NATIONAL HEALTH SPENDING 
Data on national health expenditures across emerging economies are of variable quality and restricted to recent 
years. The annual OECD Health Data ﬁles extend from 1960 to 2014 and the World Health Organization re- 
ported international comparisons of a small number of countries in 1963 and 1967 (Abel-Smith, 1967), yet for 
many years most of these estimates were limited to higher-income nations. The 1993 World Bank Development 
Report Investing in Health (Musgrove, 1993) provided data on a much wider range of countries, as did the 1995 
WHO World Health Report Bridging the Gaps (The World Health Report, 1995). WHO Health Statistics have 
been published annually since 2006 and now cover 194 countries. Procedures for producing such estimates 
have been formalized as A System of National Health Accounts (A System of Health Accounts,  2011). 
 
 
3. THE CASE OF BRICS 
Since early recognition of top performing emerging markets by Goldman Sachs back in 2001 (Building Better 
Global Economic BRICs, n.d), there has been a lot of debate on health care developments in BRICS nations 
(Brazil, Russia, India, China and South Africa). The sheer size of their populations and the pace of their 
economic development (Schrooten, 2011) make the internal developments in these nations echo around the 
world. It soon became recognized that these governments lifted hundreds of millions of people outside poverty 
over the past few decades (Watt et al., 2013). Each of these ﬁve countries faced its own challenges to provide 
comprehensive health care to its citizens. Brazil's historical development of a national health system was visibly 
marked by its great ethnogeographic diversity and difﬁculties in providing access to medical care in rural areas. 
Ground breaking developments came in early 1990s with the establishment of the national health system 
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(Sistema Único de Saúde SUS). Centuries long legacy of Russian Empire brought extensive universal health 
coverage gains only after the Revolution of 1917 with the formation of Semashko system in the early 1930s. 
Today, this country remains the only high-income one among the BRICS with signiﬁcantly higher institutional 
capacities compared to the others. India as one of the World's most multifaceted societies is the hub of rapid 
growth in network of medical facilities in urban areas and four richest federal states. Elsewhere income gaps 
and affordability of medical care for the poor remain a long-term challenge. This is the only country in the 
group that has not succeeded to substantially increase its health care spending in terms of GDP share. China 
owns the most rapidly developing health system and presents the most signiﬁcant member of the BRICS group 
in terms of global outreach. Its mammoth sized network of hospitals is largely funded by the revenues made on 
prescription medicines. Regardless of undisputed progress, medical technology innovation rate remains the 
core weakness. Gains in equity of access to medical care for the ordinary citizens living in rural areas are 
substantially higher compared to Brazil and India. South Africa is the ﬂagship national health system of the 
Sub-Saharan Africa. After the difﬁcult legacy of segregation and apartheid, it strives toward extending 
universal health coverage for its poor. Although smallest in terms of population size challenges faced by its 
health authorities shall be signiﬁcant in the long run. Overall, bold gains in living standard and purchasing 
power of citizens gives momentum for all of the BRICS to increase investment in health care far more than 
majority of nations worldwide. 
Coping strategies were deeply rooted in their diverse historical legacies and health system management and 
funding traditions. Among the major challenges were accelerated population aging (Ogura and Jakovljevic, 
2014), blossoming of prosperity diseases (Jakovljevic and Milovanovic, 2015) and massive rural urban 
migration ultimately creating some of the world's ﬁrst megacities (Veloso, n.d). National policy makers did 
their best to improve health outcomes. The successes are most visible in improved neonatal survival and 
extended longevity (Jakovljevic et al., 2015). Ever increasing coverage of poor citizens living outside major 
industrial areas as well as provision of medical beneﬁts to the unemployed and vulnerable were some of the 
landmark successes now present in all ﬁve economies (Marten et al.,  2014). 
Historical traditions of real socialism in Russia (Popovich et al., 2011) and China tended to see health care as 
consumption rather than as a productive branch of the economy (George and Manning, 1980). Large-scale 
investments in national health reforms in these two countries proved that lessons were learned. The impact   of 
population health on societal economic productivity are now broadly recognized (Bhargava et al., 2001). The 
three remaining countries each followed its own distinct pathway by embracing extensive health reforms which 
proved to be fruitful as well (Rao et al.,  2014). 
 
 
 
4. BRICS' HEALTH SPENDING OVER THE PAST TWO DECADES 
Attempts at international comparisons of health expenditure data in previous decades were heavily compro- 
mised by differing national accounting strategies and policies. Diversity of a scale was notable among 
traditional OECD free market economies. Ongoing professional debates in the 1980s led to establishment of 
the WHO National Health Accounts released in 1995. These data became publicly available and a source for 
scholarly inquiry with the launch of Global Health Expenditure database comprising 194 UN member countries 
(Global Health Expenditure Database, n.d). This coordinated international effort has achieved broad coverage 
of primary data and indicators for the vast majority of nations presented with annual values reported by the 
national authorities to WHO. 
The latest WHO NHA ofﬁcial release provides insight into the BRICS nations' health expenditures over  19 
years extending from 1995 to 2013. Analysis of these data either in nominal or purchasing power parity terms 
shows three distinct patterns (see Table I). One is a signiﬁcant rise in percentage point share of Brazil, Russia, 
India, China and South Africa in global health spending (Jakovljevic, 2015a). Another is heavy domination of 
Chinese national spending which tends to gain momentum even more in recent years. The third 
  
 
 
 
 
 
 
 
 
 
 
 
 
Table I.  BRICS' historical total health expenditures (THE) stratiﬁcation (WHO NHA data); 1995 2013 
 
 
THE per capita (current $ PPP) 
General government 
expenditure on health 
per capita (current $PPP) 
Private expenditure on 
health per capita 
(current $PPP) 
 
Out of pocket expenditure 
per capita (current $PPP) 
 
    
 
Per capita health spending 1995 2013 1995 2013 1995 2013 1995 2013 
Brazil $522 $1454 $225 $701 $298 $753 $202 $435 
Russia $301 $1587 $222 $762 $79 $824 $51 $762 
India $63 $215 $17 $69 $46 $146 $42 $125 
China $61 $646 $31 $360 $30 $285 $28 $219 
South Africa $478 $1121 $189 $543 $288 $578 $67 $80 
BRICS $285 +/— $220 $1004 +/— $572 $137 +/— $104 $487 +/— $281 $148 +/— $133 $517 +/— $294 $78 +/— $71 $324 +/— $280 
(M +/— SD)         
National health spending THE (% GDP) THE (million constant 2005 US$) THE (million current US$) THE (million current $PPP) 
 1995 2013 1995 2013 1995 2013 1995 2013 
Brazil 6.65 9.67 $46 302 $112 814 $51 153 $217 308 $84 580 $291 306 
Russia 5.36 6.55 $28 050 $64 967 $16 803 $136 670 $44 697 $226 615 
India 4.06 3.97 $18 312 $58 110 $15 377 $76 892 $59 923 $268 809 
China 3.54 5.57 $32 455 $270 803 $25 805 $511 164 $76 268 $899 581 
South Africa 7.42 8.93 $13 244 $28 000 $11 217 $31 320 $19 800 $59 175 
BRICS (M +/— SD) 5.41 +/— 1.65 6.94 +/— 2.36 N/A* N/A* N/A* N/A* N/A* N/A* 
BRICS Total N/A** N/A** $138 362 $534 695 $120 356 $973 354 $285 268 $1 745 486 
BRICS' joint Share of Global THE N/A** N/A** 4.0% 9.6% 4.7% 13.2% 10.7% 20.2% 
(%)         
*N/A not applicable; measure or indicator inappropriate because of representing average value for national level health spending among nations with extreme diversity in population 
size. 
**N/A not applicable; calculation of summary amount of percentage point share of national gross domestic product (GDP) conveys no meaningful measure. 
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pattern is probably the most surprising one in terms of past few centuries of world economic history. It is in- 
creasing long-term trend in BRICS nations global health spending share relative to the trend exhibited by the 
leading industrial G7 nations (Jakovljevic, 2015b). 
BRICS' internal policy shifts and ability to strengthen health care investment refer to per capita spending 
independent of population size (see Figure 1). In the early 1990s, Brazil was heading the group in terms of total 
per capita health expenditure. It lost momentum relative to Russia over the next 14 years. The same pattern is 
visible in general governmental, private and out-of-pocket spending. The long-term trend among all ﬁve nations 
is a signiﬁcant rise of overall per capita health spending. National authorities clearly accepted progressive 
responsibility to ﬁnancially support growing civil expectations for more expensive and innovative medical care. 
Nevertheless, the most concerning fact remains an exceptional rise in out of pocket spending in all of the 
observed health systems. 
There are major differences among these ﬁve countries in their ability to increase investment in health not 
only in absolute terms but also as a share of gross domestic product. Four out of ﬁve nations gained momen- 
tum extending signiﬁcantly their health devoted share of GDP: Brazil (+3%), China (+2%), South Africa 
(+1.5%) and Russia (+1.2%), in decreasing order of appearance (see Table I). India's health spending actually 
slightly contracted from 4.06 %GDP in 1995 to 3.97% in 2013. Recently, the Federal Government of India has 
further reduced its health budget by 20% for the ﬁnancial year 2014 2015 (Cutting Health Expenditure in India, 
2014). Negative effects of such policy are partially compensated for by strong gains in overall   welfare 
 
 
Figure 1. Total, generalgovernmental, out-of-pocketandprivatehealthexpenditurepercapitain BRICSnations1995 2013(current$PPPinter- 
national) threeyearsmovingaverageextrapolated(World Health Organization National Health Accounts Global Expendituredatabase, nd) 
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and income; hence, spending in absolute terms has recorded several fold gains. It is worth to mention that 
BRICS' mean health expenditure grew from 5.41 GDP% in 1995 to 6.94 GDP% in   2013. 
 
 
5. PROJECTIONS OF NATIONAL HEALTH EXPENDITURES TO 2025 
Forecasting methods developed for the USA and other OECD countries were applied to data from the BRICS 
economies to make the projections in Table II using a macroeconomic budgetary model in the form GDP + X 
where X is the excess growth rate of medical costs (Getzen, 2016). Macro budgetary models do not account 
for general equilibrium effects because they make use of external GDP forecasts, nor do they account for 
interactions and diversity among components such as payment sources, age, sex or illness categories, disease 
prevalence, hospital or physician supply, etc. (Lorenzoni et al., 2015). However, in practice, such rudimentary 
budgetary models have proven to be more accurate than either general equilibrium or component models when 
making prospective forecasts of future total national health expenditures spanning more than ﬁve years (Getzen, 
2015). 
Current and projected expenditures for the USA and other high-income countries that account for about 40% 
of current global expenditures on health are also shown for comparison with the BRICS projections. Excess 
growth raising the share of GDP devoted to the health sector also plays an important role. Because there is 
considerable uncertainty regarding both of these factors, it is prudent to expect that national health expenditures 
may well be more than ±15% above or below the point estimates for 2025 shown in Table II. The complexity of 
health systems and the indistinct path of future economic development make it difﬁcult or impossible to 
formulate projections that are more precise. 
 
 
6. CHALLENGES TO EFFECTIVE INVESTMENT IN HEALTH CARE 
Emerging markets such as the BRICS, Next Eleven and few other fastest developing economies present the 
peak of an iceberg of higher participation of low and middle income in world health spending (Jakovljevic and 
Getzen, 2016b). Signs of this phenomenon became visible over at least past thirty years. Most of top tier 
emerging countries belong to the so-called newly industrialized economies with notable exception of Russia 
with its strong industrial legacy of USSR. Nevertheless, internal societal tensions outsourcing from dynamic 
pace of development remain most typical among the BRICS. Part of this high tide of increased wealth is being 
 
Table II.  Projections of BRICS and the USA National Health Expenditures to  2025 
 
 Historical  Projected 
$H 2012 PPP per capita GDP share (%) Excess growth rate GDP share (%) $H 2025 per capita 
India $196 3.8 1.0% 4.3 $307 
China $578 5.4 1.7% 7.0 $1084 
S. Africa $1091 8.9 0.9% 10.0 $1413 
Brazil $1388 9.5 0.8% 10.5 $1844 
Russia $1523 6.5 1.5% 8.0 $2186 
(ex-USA)      
Hi income $3062 9.8 1.5% 11.9 $4627 
USA $8845 17 1.2% 19.9 $13 025 
World $1173 8.6 1.5% 10.4 $1795 
Sources: WHO Statistics 2015 and author projections for 2025 (see note #). 
Note#. The estimated real growth rates of per capita national income for each country are based on the averages for 1975 2010 as reported 
in the Maddison Project database, with an assumption of partial reversion toward the global mean. Estimated annual excess growth rates 
(percentage increase in health share of GDP) are based on the OECD Health Data 1975 2013 for high income countries, and on the WHO 
Health Statistics 2015 data for 2000 2012 for India, China, South Africa Brazil and Russia since earlier or more recent statistics are not 
readily available. 
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clearly transferred toward investment in health care (Jakovljevic, 2014). Some large nations like India struggle 
to increase their health spending in terms of GDP percentage (Barik and Desai, 2014). India and South Africa 
have a distinct advantage of younger populations being in earlier stage of demographic transition. Although 
population health indicators warn that extended longevity coupled with falling fertility rates are raising the por- 
tion of elderly in India as well. Nevertheless, this huge nation is about to experience demographic dividend of 
up to 150 million labor market expansion in the next few decades (King, 2012). Population aging in Russia 
continues to accelerate while China will clearly be the fastest aging large nation by 2050 (Dreaming with 
BRICs: The Path to 2050, 2003). This poses a serious risk to the ﬁnancial sustainability of their large health 
sectors (Getzen, 1992). Possibly the single most signiﬁcant challenge to the equitable and affordable provision 
of medical services in these countries are increasing income disparities among their citizens (Bloom and 
McIntyre, 1998) with partial exception of Brazil (de Marsilllac MelsertII and BockII, 2015). Although the civil 
middle class and its purchasing power are rapidly growing, there is a deepening gap between rich elites and 
poor households mostly residing outside major urban cores in the rural countryside. An indicator of the 
seriousness of this issue is the constantly growing out of pocket expenses for health care that become a frequent 
cause of ﬁnancial catastrophe for households (McIntyre et al., 2006; Jakovljevic, 2016). Development of 
strategies designed to bridge this equity gap might be critical for the success of these health systems in the long 
run (Harris et al., 2011). 
Existing health care sectors in the BRICS economies may not be sufﬁcient to meet rising population demand 
for medical services (Rodwin, 2015). The Russian Constitution guarantees (article 41) that all medical care 
provided in public facilities is free of charge covered by public ﬁnancing. Outpatient medicines dispensing is 
omitted from this rule. Privileged vulnerable social groups make an exception from this rule. It means that most 
population needs for medical care could be met by public sector or complimented by     public ﬁnanced private 
providers (European Observatory on Health Systems,  Policies,  and  Popovich,  2011). In most of BRICS 
countries local pharmaceutical markets tend to be dominated by generic instead     of brand-name medicines 
(Jakovljevic et al., 2016c). Nevertheless, because of local reimbursement policies, certain medicines, 
particularly cutting-edge innovative technologies remain largely unaffordable to the ordinary citizens 
(Popovich, 2013). Some weaknesses inherited from the past include the inefﬁciencies of large massive hospital 
sectors in curative based health systems. Eastern Europe was famous for its relative oversupply of physicians 
and higher availability of hospital bed capacities compared to the West  (Jakovljevic, 2013). Such bed capacities 
tended to be under-occupied and generate excessive length of hospital stay after admission in some clinical 
areas. A partial exemption of this trend was the Russian tradition of authorities' regular check-ups of hospital 
utilization indicators such as bed occupancy rate and     if it was too low the department could face closure 
(Atun et al., 2005). More preventive public health- oriented system reforms have been attempted in all BRICS 
nations with diverse rates of success over the   past three decades (Coovadia et al.,   2009). 
Deep positive changes to replace outdated and malfunctioning health policies are taking place in all         of 
these nations (Jakovljevic et al., 2016). Whether the  BRICS  nations  will  continue  to  strive  to  im- prove 
universal and comprehensive health coverage in the long run shall be observed in the upcoming decades. 
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